Skip to main content

Healthy Male Adults

2
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

JW Pharmaceutical
JW PharmaceuticalKorea - Seoul
1 program
1
14C Epaminurad Oral SolutionPhase 11 trial
Active Trials
NCT07036458Completed8Est. Sep 2025
Otsuka
OtsukaJapan - Tokushima
1 program
1
ASC-01Phase 11 trial
Active Trials
NCT03342963Completed74Est. Jan 2018
Santen
SantenCA - Emeryville
1 program
DE-117PHASE_11 trial
Active Trials
NCT02650063Completed14Est. Mar 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
JW Pharmaceutical14C Epaminurad Oral Solution
OtsukaASC-01
SantenDE-117

Clinical Trials (3)

Total enrollment: 96 patients across 3 trials

NCT07036458JW Pharmaceutical14C Epaminurad Oral Solution

To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects

Start: Aug 2025Est. completion: Sep 20258 patients
Phase 1Completed
NCT03342963OtsukaASC-01

Bioequivalence Between Single Administration of ASC-01 (Aripiprazole/Sertraline Combination Drug) and Concomitant Single Administration of Aripiprazole and Sertraline, and Food Effect on Pharmacokinetics of ASC-01 in Healthy Male Adults

Start: Nov 2017Est. completion: Jan 201874 patients
Phase 1Completed
NCT02650063SantenDE-117

A Pharmacokinetic Study of DE-117 Ophthalmic Solution in Healthy Adult Male Subjects - Phase I Study -

Start: Dec 2015Est. completion: Mar 201614 patients
Phase 1Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.